Stocks and Investing Stocks and Investing
Wed, December 15, 2021
Tue, December 14, 2021

Swayampakula Ramakanth Maintained (XFOR) at Strong Buy with Decreased Target to $11 on, Dec 14th, 2021


Published on 2024-10-27 18:58:38 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $21 to $11 on, Dec 14th, 2021.

Swayampakula, nor any peers, have made any analyst calls on XFOR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources